Abbott launches FreeStyle InsuLinx, new control system of glucose which includes a rapid insulin dose calculator

Madrid, 2012-may Abbott presents a new system called blood glucose control ‘ FreeStyle InsuLinx ’. It’s the first system of control of blood glucose of Abbott which includes a calculator dose flexible rapid insulin (bolus) that adapts to the needs of patients in therapy basal bolus.

The new meter FreeStyle InsuLinx offers useful functions for the patient as a touch screen, a book of automated registration, preferences for personalization and the possibility of connecting via USB to easily send reports with FreeStyle Auto-Assist data management software. The FreeStyle InsuLinx system is now available in our country since the month of April.

In Europe there are approximately 55.4 million people with diabetes, of which approximately 3.1 million live in Spain. Around about 360,000 require or rely on insulin to control their disease.

The correct calculation of the dose of insulin is one of the main difficulties they encounter in their treatment. According to a study, nearly 60% of people with diabetes make mistakes in the calculation of the dose of insulin. In particular, only 41 per cent of people with diabetes were capable of calculating these doses by adjusting the intake of carbohydrates and glucose in sangre6.

In view of the Dr. Francisco Javier of thatched Gómez, Chief of service Endrocrinología and nutrition of the Hospital Infanta Leonor of Madrid, en los pacientes en tratamiento con multiple doses of insulin, the adjustment of dosage is essential to maintain the levels of glucose within the objectives. Calculate the dose of insulin, suitable for every meal can be a complicated process for the patient which may include complex mathematical calculations ”.

The new FreeStyle InsuLinx control system of glucose and that could benefit in Spain more than 360,000 people with diabetes mellitus en tratamiento con multiple doses of insulin, includes a very easy to use rapid insulin dose calculator. “The added value of FreeStyle InsuLinx is that he eases patients obtain a better metabolic control, through a better grip and completion of treatment, minimizing the possibility of error in the calculation of the dose of insulin,” said during the presentation.

About Abbott Diabetes Care

Abbott Diabetes Care, headquartered in Alameda (California, USA)(UU.), is a leading company in the development, manufacture and marketing of glucose control systems, designed to help people better manage their diabetes.

About Abbott

Abbott is a biomedical company dedicated to the discovery, development, manufacture and marketing of pharmaceuticals, nutritional, health and diagnosis. The company employs 91,000 people worldwide and sells its products in more than 130 countries.

Abbott is certified as Top Employers Spain 2011 by CRF Institute, and as the best company to work in the health sector and the second in the general ranking of sectors according to Best 2009″ Spain 2010. Abbott has over 1,500 employees and 61 years of history in our country. The company’s activity is oriented to meet the needs of patients with chronic diseases and high clinical, economic, social, and emotional impact. Abbott has a presence in all areas of the Spanish healthcare industry (including r & d and manufacturing at its centres in Madrid, Granada and Alcobendas). Its products cover all phases of the process of the disease (prevention, diagnosis, treatment and healing) and are present at every moment of the life cycle: newborn, childhood, adolescence, maturity and old age.